Welcome to LookChem.com Sign In|Join Free

CAS

  • or

934664-27-4

Post Buying Request

934664-27-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1,1-dimethylethyl 2-(3-hydroxy-1-{[(phenylmethyl)oxy]carbonyl}azetidin-3-yl)piperidine-1-carboxylate

    Cas No: 934664-27-4

  • No Data

  • No Data

  • No Data

  • NovaChemistry
  • Contact Supplier

934664-27-4 Usage

General Description

Tert-butyl 2-(1-(benzyloxycarbonyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate is a chemical compound that belongs to the class of azetidines, which are four-membered heterocycles containing one nitrogen atom. It is a derivative of piperidine, a heterocyclic amine, and contains a benzyl ester group and a tert-butyl group. tert-Butyl 2-(1-(benzyloxycarbonyl)-3-hydroxyazetidin-3-yl)piperidine-1-carboxylate can be used in organic synthesis as a building block for the preparation of various pharmaceuticals and biologically active molecules. Its structure includes a piperidine ring with a hydroxy group, an azetidine ring, and a tert-butyl ester, which makes it important for medicinal chemistry research and drug development.

Check Digit Verification of cas no

The CAS Registry Mumber 934664-27-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,4,6,6 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 934664-27:
(8*9)+(7*3)+(6*4)+(5*6)+(4*6)+(3*4)+(2*2)+(1*7)=194
194 % 10 = 4
So 934664-27-4 is a valid CAS Registry Number.

934664-27-4Relevant articles and documents

PROCESS FOR THE PRODUCTION OF COBIMETINIB

-

, (2019/05/22)

The present invention relates to a novel route of synthesis for the production of enantiomerically pure Cobimetinib, new intermediates in the synthesis of Cobimetinib and an amorphous Cobimetinib hemifumarate salt comprising a high salt content.

METHODS OF USING MEK INHIBITORS

-

Page/Page column 332, (2008/12/06)

The present invention provides methods of treating cancer by administering a compound of Formula (I), or a pharmaceutically acceptable salt or solvate thereof, in combination with other cancer treatments.

AZETIDINES AS MEK INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISEASES

-

Page/Page column 168, (2008/06/13)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 934664-27-4